When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Ethyl eicosapentaenoic acid - Wikipedia

    en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

    Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia [4] and hypertriglyceridemia. [3] It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150 mg/dL.

  3. How Much Does Vascepa Cost on Medicare? - AOL

    www.aol.com/much-does-vascepa-cost-medicare...

    How much will you pay for Vascepa under Medicare? According to Optum Perks, 30 capsules of Vascepa can cost between $91 and $99 without insurance, depending on the pharmacy you get them from.

  4. Amarin Corporation - Wikipedia

    en.wikipedia.org/wiki/Amarin_Corporation

    Amarin´s sole product VASCEPA® came on the market in 2013 for triglyceride levels >=500 milligrams per deciliter. In December 2019, the FDA approved "...the use of Vascepa (icosapent ethyl) as an adjunctive (secondary) therapy to reduce the risk of cardiovascular events among adults with elevated triglyceride levels (a type of fat in the blood) of 150 milligrams per deciliter or higher.

  5. Patient portal - Wikipedia

    en.wikipedia.org/wiki/Patient_portal

    Some patient portal applications enable patients to register and complete forms online, which can streamline visits to clinics and hospitals. Many portal applications also enable patients to request prescription refills online, order eyeglasses and contact lenses, access medical records, pay bills, review lab results, and schedule medical ...

  6. Investigators to Present New REDUCE-IT Subanalysis of VASCEPA ...

    lite.aol.com/tech/story/0022/20241111/9270771.htm

    DUBLIN and BRIDGEWATER, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that investigators will present an additional subgroup analysis from the landmark REDUCE-IT outcomes trial in patients with and without coronary artery disease (CAD) history and mechanistic data on eicosapentaenoic acid (EPA) at the American Heart Association’s Scientific ...

  7. Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA ...

    lite.aol.com/tech/story/0022/20240909/9227242.htm

    DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that new supported and/or funded research on the clinical impact of VASCEPA ® /VAZKEPA (icosapent ethyl) in patients with diabetes and high cardiovascular risk and the anti-Lp(a) oxidation mechanistic effects of eicosapentaenoic acid (EPA) will be presented at the 60 ...

  8. How Do You Solve a Problem Like Vascepa?

    www.aol.com/2012/11/03/how-do-you-solve-a...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Omega-3-carboxylic acids - Wikipedia

    en.wikipedia.org/wiki/Omega-3-carboxylic_acids

    Omega−3-carboxylic acids are used in addition to changes in diet to reduce triglyceride levels in adults with severe (≥ 500 mg/dL) hypertriglyceridemia. [6]Intake of large doses (2.0 to 4.0 g/day) of long-chain omega−3 fatty acids as prescription drugs or dietary supplements are generally required to achieve significant (> 15%) lowering of triglycerides, and at those doses the effects ...